LABORATORY NEWS
-
Sherlock Biosciences Acquires Sense Biodetection Advancing CRISPR-Based Diagnostics For Consumers
Sherlock Biosciences, a company engineering biology to bring next-generation diagnostics to the point of need, today announced the acquisition of Sense Biodetection (Sense), a global molecular diagnostics innovator.
- GTG To Form Strategic Alliance With Global Testing Leader QIAGEN
- Biosynex And Chembio Diagnostics Announce Definitive Acquisition Agreement
- Beckman Coulter And MeMed To Expand Access To Proven Host Immune Response Diagnostic Able To Distinguish Between Bacterial And Viral Infections
- Guardant Health To Integrate Lunit's AI-Based Scoring Algorithm For PD-L1 Into Its Portfolio To Enhance Cancer Biomarker Detection
ARCHIVED NEWSLETTER
- 01.24.23 -- FDA Seeks Comment On Circumstances For Delaying, Denying, Limiting, Or Refusing An Inspection
- 01.10.23 -- ICH Issues Draft Guideline On Viral Safety Evaluation Of Biotech Products
- 12.20.22 -- How Can Nanomedicine Innovations Combat Cancer?
- 12.06.22 -- Digital Twins & The CGT Value Chain: A Universe Of Possibilities
- 11.22.22 -- Pharma 4.0 Software Methodologies In Biopharma & Medical Devices
This website uses cookies to ensure you get the best experience on our website. Learn more